AbbVie is acquiring Amgen-backed DJS Antibodies for $255m while Legend Holdings took part in a $56.6m series C round for VectorBuilder.

M&A DJS Antibodies, the UK-based inflammatory disease-focused antibody therapy developer backed by Amgen, has been acquired by another pharmaceutical firm, AbbVie, for $255m. Amgen unit Amgen Ventures contributed to an $8.4m round for the company in late 2020. Metaverse developer Translucia has purchased Infofed, the Thailand-based esports software platform that counts video game media group GameWith and event management portal operator EventPop as investors, for an undisclosed amount. Naborly, the US-based credit check services provider backed by rental insurance group Assurant Insurance, has been bought by property technology company SingleKey for an undisclosed sum. Assurant took part in its $7.5m seed round in 2019. Home automation service has acquired US-based personal safety app developer Noonlight for an undisclosed amount, allowing online dating platform operator Match Group to exit. The company had raised $12m before Match added an undisclosed sum in early 2020. Fund US-based flexible office provider Workbox has formed a corporate venturing arm called Workbox Ventures to back developers of products focusing on the future of work, covering human resources, financial and property technology. Phillip Leslie will oversee the unit as managing partner. Public markets Prime Medicine, the US-based curative genetic therapy developer backed by internet technology group Alphabet, has listed on the Nasdaq Global Market in a $175m initial public offering. Alphabet unit GV held a 14.6% stake prior to the IPO, which involved Prime issuing almost 10.3 million shares priced at $17.00 each. Droom Technology, the India-based online automotive marketplace backed by multiple corporates, has cancelled a $361m initial public offering. It had filed for the IPO on the Securities and Exchange Board of India in November 2021. Funding CompanyCompany descriptionSectorCountryRoundRound size($m)Deal dateInvestorsVectorBuilder Gene delivery technology developerHealthcareChinaC56.620/10/2022Legend Holdings (Legend Capital); Guzngzhou Industrial Investment and Capital Operation Group, Yuexiu Financial Holdings (Industrial Fund), Wanlian Securities, Suikai InvestmentBanyanStock data network operatorFinancialUSA4320/10/2022FIS Impact Ventures; Fin Capital (co-lead), M13 (co-lead), Western Alliance Bank (Bridge Bank), Interplay, TTV CapitalSubjectWellChronic disease diagnosis platformHealthcareUSB3520/10/2022Bertelsmann; Asset Management Ventures (lead), Healthy Ventures, Windham Venture Partners, Geekdom FundPIC Therapeutics Drug-resistant breast cancer treatment developerHealthcareUSA3519/10/2022Harrington Discovery Institute; OrbiMed (lead), Lumira Ventures, Advent Life Sciences, Belinda TermeerBaseload CapitalGeothermal climate investment fundEnergy and Natural ResourcesSwedenN/A2420/10/2022Chevron (Chevron Technology Ventures), Baker Hughes; Breakthrough Energy (Breakthrough Energy Ventures), Sustainable Development Capital, Gullspång Invest SkuafDigital payroll platformFinancialSingaporeA1519/10/2022Gojek (Go-Ventures) (lead), Mindlance; Beenext, Anthemis, NMVM, unnamed angel investorsLevidianGraphene-based hydrogen energy providerEnergy and Natural ResourcesUKN/A13.420/10/2022Baker HughesLimber HealthMusculoskeletal care providerHealthcareUSA1121/10/2022Blue Cross and Blue Shield (Blue Venture Fund); Glenview Capital OrdoOpen banking fintech platform FinancialUKA1119/10/2022Equinox Systems (lead)VestrInvestment management platformFinancialSwitzerlandN/A9.819/10/2022Raiffeisen Bank International (Elevator Ventures) (lead), Zürcher…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?
Edison Fu

Edison Fu is a reporter and Asia liaison at Global Corporate Venturing.